STAT News

STAT+: Pharmalittle: We’re reading about India’s new manufacturing rules, clinical trials in China, and more

India proposed rules requiring regulators to immediately suspend manufacturing licenses for drugs that fail quality standards in government testing

By STAT News

1 min read
STAT+: Pharmalittle: We’re reading about India’s new manufacturing rules, clinical trials in China, and more
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights